Validation of the ALBI Grade ‐based Integrated Model as a Predictor for Sorafenib‐failed Hepatocellular Carcinoma

ConclusionsALBI‐PD criteria can differentiate PPS and stratify the patients with advanced HCC for the second‐line trials or salvage therapy.This article is protected by copyright. All rights reserved. (Source: Liver International)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2utirSz
via IFTTT